Canntab Therapeutics Limited announced that it has entered into a service agreement with Pathway Health Corporation. Pathway Health is one of the providers of out-of-hospital pain management services in Canada. The company owns and operates nine (9) community-based clinics across four provinces. Pathway Health's team of healthcare professionals and clinic staff can assess and treat patients with chronic pain or those interested in medical cannabis. Canntab Therapeutic's full suite of oral tablet products consisting of a range of both THC and CBD strengths will be available to patients served by Pathway Health. Canntab believes this type of dosage format will be preferred by certain patients ? such as those in the senior demographic, who are largely interested in a product that is easy to administer and yet, is also titratable due to the availability of different strengths. On November 11, 2021, Canntab received its medical sales license from Health Canada for its Markham, Ontario facility, enabling the sale of all products directly to medical consumers. The amendment marked the final regulatory step required to launch the company's direct to consumer website, allowing patients across Canada with an authorized medical document to order online, Canntab's unique patented exact dosage tablets and caplets of THC and CBD in various strengths. Exact dosing and ease of administration are the key elements in the Canntab offering, which specifically addresses the needs of the medical community and patients.